Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ting Deng, Yin Lin, Li Chen & Jun-Ying Jiang. (2023) Comparison of Dydrogesterone and GnRH-a Effects After Laparoscopic Surgery in Patients with Stage III and IV Endometriosis. International Journal of General Medicine 16, pages 4357-4364.
Read now
Read now
Johannes Ott, Christian Egarter & Alex Aguilera. (2022) Dydrogesterone after 60 years: a glance at the safety profile. Gynecological Endocrinology 38:4, pages 279-287.
Read now
Read now
Petra Stute. (2021) Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman’s journey. Gynecological Endocrinology 37:8, pages 683-688.
Read now
Read now
Qian Chen, Da Zhang, Shu Wang, Jing-He Lang, Xiao-Pei Chao & Qing-Bo Fan. (2021) A prospective, open-label, single-arm study to evaluate the efficacy of dydrogesterone in the treatment of endometrial polyps. Gynecological Endocrinology 37:2, pages 152-156.
Read now
Read now
Articles from other publishers (9)
O. L. Lovkina, N. G. Masibroda, O. A. Muntyan, V. V. Klivak & A. V. Vozniuk. (2023) The impact of today’s chronic stress on a woman’s menstrual function. Reports of Vinnytsia National Medical University 27:2, pages 331-335.
Crossref
Crossref
Elham Naghshineh, Hatav Ghasemi Tehrani, Fatemeh Sharifian & Somayeh Haghighat. (2023) A comparison of oral dydrogesterone with vaginal progesterone for luteal-phase support in in vitro fertilization: A randomized controlled trial. Advanced Biomedical Research 12:1, pages 132.
Crossref
Crossref
Yue Liu, Xin Yu, Jing Huang, Chengchao Du, Honggui Zhou, Yamei Yang & Dacheng Qu. (2022) Additional dydrogesterone for the treatment of chronic endometritis treated with antibiotic in premenopausal women with endometrial polyps: a retrospective cohort study. BMC Women's Health 22:1.
Crossref
Crossref
Tanja K. Eggersmann, Albert Wolthuis, Peter H. van Amsterdam & Georg Griesinger. (2022) Lack of analytical interference of dydrogesterone in progesterone immunoassays. Clinical Chemistry and Laboratory Medicine (CCLM) 60:7, pages 1039-1045.
Crossref
Crossref
Nisarath Soontrapa, Manee Rattanachaiyanont, Malee Warnnissorn, Thanyarat Wongwananuruk, Suchada Indhavivadhana, Prasong Tanmahasamut, Kitirat Techatraisak & Surasak Angsuwathana. (2022) The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial. Scientific Reports 12:1.
Crossref
Crossref
- -. (2021) Resolution of the 1st Ukrainian expert forum on abnormal uterine bleeding. REPRODUCTIVE ENDOCRINOLOGY:62, pages 64-74.
Crossref
Crossref
Gennady T. Sukhikh, Leila V. Adamyan, Svetlana O. Dubrovina, Igor I. Baranov, Vitaly F. Bezhenar, Andrey V. Kozachenko, Viktor E. Radzinsky, Mekan R. Orazov, Maria I. Yarmolinskaya & Jan I. Olofsson. (2021) Prolonged cyclical and continuous regimens of dydrogesterone are effective for reducing chronic pelvic pain in women with endometriosis: results of the ORCHIDEA study. Fertility and Sterility 116:6, pages 1568-1577.
Crossref
Crossref
Dacheng Qu, Maomei Yang, Lina Tong, Xin Yu, Qiao Jing, Yamei Yang & Honggui Zhou. (2021) Combination of Dydrogesterone and Antibiotic Versus Antibiotic Alone for Chronic Endometritis: a Randomized Controlled Trial Study. Reproductive Sciences 28:11, pages 3073-3080.
Crossref
Crossref
Lu Wang, Hai-Yun Guan, He-Xia Xia, Xiu-Ying Chen & Wei Zhang. (2020) Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding – ovulation dysfunction patients. World Journal of Clinical Cases 8:15, pages 3259-3266.
Crossref
Crossref